CapWealth trims Gilead stake by 5.2%
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
CapWealth Advisors LLC cut its Gilead Sciences stake by 5.2%, selling 12,110 shares while retaining 221,671 shares valued at $33.0 million. The sale follows insider selling totaling Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context